The Mets made a savvy bullpen move by re-signing right-handed reliever Drew Smith to a one-year, $1 million deal, which includes a $2 million club option for 2026. While Smith won’t be an immediate contributor due to Tommy John surgery, the Mets are betting on his recovery and long-term upside.
A Recovery Timeline That Could Align with a Playoff Push
Smith, 31, underwent Tommy John surgery and is expected to miss most of the 2025 season. However, if his rehab progresses smoothly, there’s an outside chance he could return late in the year, potentially giving the Mets an additional bullpen weapon for a postseason push.